CR decreases intramyocellular lipid content, blood pressure, total cholesterol, LDL cholesterol, C-reactive protein, TNFα, and 10-year risk of cardiovascular disease (Das et al., 2007; Rochon et al., 2011; Stewart et al., 2013). The gene discussed is TNF; the disease is cardiovascular disorder.